Premium
Ephedrine in the cat lung vasculature
Author(s) -
Fields A. M.,
Richards T. A.,
Ibrahim I. N.,
Kaye A. D.
Publication year - 2003
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1034/j.1399-6576.2003.00185.x
Subject(s) - phentolamine , ephedrine , prazosin , medicine , blood pressure , anesthesia , norepinephrine , perfusion , adrenergic receptor , antagonist , pharmacology , receptor , propranolol , dopamine
Background: Ephedrine is one of the most commonly used non‐catecholamine sympathomimetic agents. It is used in operating rooms and critical care settings worldwide. While it has many side effects, its ability to rapidly raise blood pressure makes it an ideal agent to maintain homeostasis as well as in emergency situations. While its effects are known to be mediated by an α‐mediated mechanism, the exact α subtype is unknown. In addition, no studies using ephedrine have been performed in the pulmonary vascular bed of the cat. Methods: The effects of phentolamine, a non‐selective α‐receptor blocker, and prazosin, an α 1 ‐selective antagonist, were investigated on pulmonary arterial responses to ephedrine, phenylepherine, norepinephrine, and U‐46619. Lobar arterial perfusion pressure was continuously monitored, electronically averaged, and recorded with constant flow in the isolated left lower lobe vascular bed of the cat. Results: Phentolamine and prazosin significantly reduced vasoconstrictor pulmonary perfusion pressure increases induced by ephedrine. Conclusion: Ephedrine has significant vasopressor activity in the pulmonary vascular bed of the cat meditated predominantly by α1 adrenergic receptor activation.